Status:
UNKNOWN
Osteopathic Approach in Inflammatory Bowel Diseases
Lead Sponsor:
Ecole Professionnelle des Osteopathes du Quebec
Conditions:
Inflammatory Bowel Diseases (IBD)
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Crohn's disease (CD) and ulcerative colitis are bowel disease (IBS) with an autoimmune component believed to affect approximately 1 in 140 Canadians. Despite this high prevalence, more than 30% patien...
Detailed Description
For this study, 10 to 12 participant (18 to 65 years) with Inflammatory Bowel Disease (in remission state) will be recruited to receiving visceral osteopathic therapy. Participant will received four s...
Eligibility Criteria
Inclusion
- Subjects diagnosed with inflammatory bowel disease (IBD) in remission state;
- Subjects must suffer form recurrent digestive symptoms fulfilling the Rome III criteria;
- Subjects' eating habits should be stable prior to the study.
Exclusion
- Concomitant diagnosis of celiac disease or multiple food intolerance;
- Concomitant diagnosis of rheumatologic disease;
- Obesity (BMI ≥ 30);
- Concomitant diagnosis of severe depression or severe anxiety;
- Unstable thyroid or kidney condition;
- Subjects on antidepressant, anti-inflammatory (steroids) or analgesic (paracetamol, aspirin) will be excluded from the study;
- Smokers, patients with problematic alcohol consumption or consuming drugs will be excluded from the study;
- High performance athletes will be excluded from the study.
Key Trial Info
Start Date :
April 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04805749
Start Date
April 15 2021
End Date
September 1 2021
Last Update
March 18 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.